Restoration of RUNX3 enhances transforming growth factor‐β‐dependent p21 expression in a biliary tract cancer cell line

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Science

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2007.00460.xPMID 17470130PMCID PMC11159762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RUNX3 Cooperates with FoxO3a to Induce Apoptosis in Gastric Cancer Cells*

  2006cited by this paper
• Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis.

  2005cited by this paper
• RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

  2005cited by this paper
• Possible Involvement of RUNX3 Silencing in the Peritoneal Metastases of Gastric Cancers

  2005cited by this paper
• Smad transcription factors.

  2005cited by this paper
• Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells.

  2005cited by this paper
• RUNX3 Suppresses Gastric Epithelial Cell Growth by Inducing p21WAF1/Cip1 Expression in Cooperation with Transforming Growth Factor β-Activated SMAD

  2005cited by this paper
• The endocannabinoid system drives neural progenitor proliferation

  2005cited by this paper
• 1'-acetoxychavicol acetate is a novel nuclear factor kappaB inhibitor with significant activity against multiple myeloma in vitro and in vivo.

  2005cited by this paper
• Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.

  2004cited by this paper
• Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers

  2004cited by this paper
• Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.

  2004cited by this paper
• RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.

  2004cited by this paper
• The epidemiology of cholangiocarcinoma.

  2004cited by this paper
• Growth regulation of gastric epithelial cells by Runx3

  2004cited by this paper
• Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

  2004cited by this paper
• Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma

  2004cited by this paper
• Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia

  2004cited by this paper
• Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer.

  2004cited by this paper
• Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis

  2004cited by this paper
• Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.

  2003cited by this paper
• Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.

  2003cited by this paper
• Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation

  2003cited by this paper
• Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers

  2003cited by this paper
• Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines

  2003cited by this paper
• Non-malignant and Tumor-derived Cells Differ in Their Requirement for p27Kip1 in Transforming Growth Factor-β-mediated G1 Arrest*

  2002cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• Causal relationship between the loss of RUNX3 expression and gastric cancer.

  2002cited by this paper
• c-myc Is a Downstream Target of the Smad Pathway* 210

  2002cited by this paper
• Disrupted transforming growth factor‐β signaling and deregulated growth in human biliary tract cancer cells

  2000cited by this paper
• p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells.

  2000cited by this paper
• How cells read TGF-β signals

  2000cited by this paper
• How cells read TGF-beta signals.

  2000cited by this paper
• p21cip1 mRNA is controlled by endogenous transforming growth factor‐β1 in quiescent human hematopoietic stem/progenitor cells

  2000cited by this paper
• Molecular basis of tissue‐specific gene expression mediated by the Runt domain transcription factor PEBP2/CBF

  1999cited by this paper
• Biliary tract cancers.

  1999cited by this paper
• Interaction and Functional Cooperation of PEBP2/CBF with Smads

  1999cited by this paper
• Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.

  1998cited by this paper
• Transforming Growth Factor-β1 Stimulates or Inhibits Cell Growth via Down- or Up-Regulation of p21/Waf1

  1998cited by this paper
• TGF-β signalling from cell membrane to nucleus through SMAD proteins

  1997cited by this paper
• Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells

  1997cited by this paper
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.

  1996cited by this paper
• A Large Variety of Alternatively Spliced and Differentially Expressed mRNAs Are Encoded by the Human Acute Myeloid Leukemia Gene AML1

  1996cited by this paper
• Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site.

  1995cited by this paper
• Transforming Growth Factor (cid:2) -Dependent Sequential Activation of Smad, Bim, and Caspase-9 Mediates Physiological Apoptosis in Gastric Epithelial Cells†

  year unknowncited by this paper

• RUNX3: A Location-oriented Genome Coordinator

  2023cites this paper
• RUNX3/H3K27me3 Co-Expression Defines a Better Prognosis in Surgically Resected Stage I and Postoperative Chemotherapy-Naive Non-Small-Cell Lung Cancer

  2022cites this paper
• Significance of pSmad2/3 and Smad4 in hepatitis C virus‐related liver fibrosis and hepatocellular carcinoma

  2018cites this paper
• Runx3 and Cell Fate Decisions in Pancreas Cancer.

  2017cites this paper
• Truncated forms of RUNX3 Unlike Full Length Protein Alter Cell Proliferation in a TGF-β Context Dependent Manner

  2017cites this paper
• Human endometrial DNA methylome is cycle-dependent and is associated with gene expression regulation.

  2014cites this paper
• IGF-1-Induced Enhancement of PRNP Expression Depends on the Negative Regulation of Transcription Factor FOXO3a

  2013cites this paper
• RUNX3 interactome reveals novel centrosomal targeting of RUNX family of transcription factors

  2012cites this paper
• TGF-β mediated DNA methylation in prostate cancer

  2012cites this paper
• Absence of Runx3 expression in normal gastrointestinal epithelium calls into question its tumour suppressor function

  2011cites this paper
• Gene profile analysis of CD8(+) ILT3-Fc induced T suppressor cells.

  2011cites this paper
• Runx3 Expression Inhibits Proliferation and Distinctly Alters mRNA Expression of Bax in AGS and A549 Cancer Cells

  2011cites this paper
• Dysfunctional transforming growth factor‐β signaling with constitutively active notch signaling in Barrett's esophageal adenocarcinoma

  2011cites this paper
• Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis

  2011cites this paper
• Expression Profiles of PIK3CA, RUNX3, COX-2 and DMBT1 Genes In Brain Tumor Prognosis: A preliminary study

  2010cites this paper
• RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.

  2010cites this paper
• Runx1 Is a Co-activator with FOXO3 to Mediate Transforming Growth Factor β (TGFβ)-induced Bim Transcription in Hepatic Cells*

  2009cites this paper
• Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients.

  2009cites this paper
• DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.

  2009cites this paper
• Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.

  2008cites this paper
• Influence of prothymosin-alpha on HIV-1 target cells.

  2007cites this paper
• Influence of Prothymosin‐α on HIV‐1 Target Cells

  2007cites this paper